Skip to content

Research on the Therapeutic Application of oXiris-CRRT in Patients with Return of Spontaneous Circulation After Cardiac Arrest

Research on the Therapeutic Application of oXiris-CRRT in Patients with Return of Spontaneous Circulation After Cardiac Arrest

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100704
Enrollment
Unknown
Registered
2025-04-14
Start date
2025-02-27
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Return of Spontaneous Circulation After Cardiac Arrest

Interventions

Intervention Group 1:Mild Hypothermia Therapy: Administer cooling blanket devices, ice caps, and hibernation mixture for targeted temperature management. CRRT with oXiris Filter: Perform continuous re
Intervention Group 2:Mild Hypothermia Therapy: Administer cooling blanket devices, ice caps, and hibernation mixture for targeted temperature management. CRRT with ST100 Filter: Perform continuous ren
Control Group:Mild Hypothermia Therapy: Administer cooling blanket devices, ice caps, and hibernation mixture for targeted temperature management.

Sponsors

Nantong Third People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >=18 years; 2.Patients successfully resuscitated from cardiac arrest; 3.ICU admission duration >=24 hours; 4.Patients meeting clinical indications for CRRT must provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Age <18 years; 2. Severe underlying diseases (e.g., advanced cancer, end-stage renal disease, end-stage liver disease, severe cardiopulmonary dysfunction); 3. Uncontrolled infection or uncontrolled severe infection sources; 4. Severe coagulation dysfunction (e.g., DIC) or intolerance to anticoagulant therapy; 5. Use of other blood purification devices: Prior use of other blood purification devices within 24 hours before enrollment (e.g., other types of CRRT, hemoperfusion); 6. Family refusal to participate; 7. Other study-related exclusion factors: Any additional conditions deemed by the research team to compromise patient safety or study validity.

Design outcomes

Primary

MeasureTime frame
Cerebral performance category;ICU mortality rate;ICU mortality rate;ICU expenses;

Secondary

MeasureTime frame
Speed and rate of achieving body temperature standards;Duration of ICU stay;

Countries

China

Contacts

Public ContactWang Yadong

Nantong Third People’s Hospital

wangyadong8230@163.com+86 136 4629 9580

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026